Navigation Links
PharmaNet Development Group Experts to Share Insights at the 9th Annual Partnerships in Clinical Trials Conference in Vienna
Date:11/1/2010

PRINCETON, N.J., Nov. 1, 2010 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, today announced its experts will share their insights on key industry topics during the 9th Annual Partnerships in Clinical Trials Conference taking place from 16-19 November at Reed Messe in Vienna, Austria.  

At the conference, members of PharmaNet's management team will discuss the opportunities and challenges currently facing the CRO industry, including the impact of the economic environment on drug development and the need for innovative collaboration in post-marketing studies and biosimilar development.  

Wednesday 17 November 2010 Dalvir Gill, PhD, President, Late Stage Development, will give a keynote presentation, "Surviving Difficult Times: How Much Has the Recession Really Affected Clinical Outsourcing and How Does the Industry Need to Change?"

Jeff Trotter, Executive Vice President, Phase IV Development, will present "Successful Approaches to Partnering in Post-Marketing Studies."

Thursday 18 November 2010Dr. Pablo Fernandez, LMS, FFPM, Senior Vice President, Medical Affairs, will present "Partnering to Overcome the Challenges of Biosimilar Development."

Conference attendees can learn more about PharmaNet's capabilities by visiting booth 129 in the exhibition hall where an international team of representatives will be available to discuss PharmaNet's expertise in helping clients reach their goal of delivering safe and effective therapeutics to patients.

About PharmaNet Development Group, Inc.PharmaNet Development Group, a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit www.PharmaNet.com. Contact: Anne-Marie HessPhone:   (609) 951-6842E-mail:   ahess@pharmanet.com
'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaNet Development Group Appoints Anthony Maida, Vice President, Clinical Research
2. Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer
3. SEC Closes Investigation of PharmaNet Development Group and Recommends No Action
4. Christopher Brennan Joins PharmaNet Development Group as General Counsel
5. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
6. PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
7. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
8. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
9. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
10. PharmaNet Development Group Agrees to be Acquired by JLL Partners
11. Thrombosis Experts Present Update on Important New Developments in Anticoagulation Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jose, CA (PRWEB) , ... January 17, 2017 , ... ... cultivate a balanced, peaceful and healthy lifestyle, announced today the official launch of its ... and frees the mind. , In development for over a year, the ...
(Date:1/17/2017)... ... January 17, 2017 , ... NeoTrident, a leading provider ... and performance management systems for high-consequence industries, announced today that they have entered ... sciences industry, organizations must pay much more attention to the quality of products ...
(Date:1/17/2017)... , Jan. 17, 2017  Protagonist Therapeutics, ... that it has initiated a global Phase 2b ... oral peptide that targets alpha4beta7 integrin. The aim ... is to evaluate the safety/tolerability and efficacy of ... with moderate to severe active disease. ...
(Date:1/16/2017)... ... January 16, 2017 , ... Appellate ... its decision on the appeal filed by India-based Dishman Pharmaceutical & Chemical Ltd. ... against DPCL and one of its Dishman Group’s 100% wholly owned New Jersey-based ...
Breaking Biology Technology:
(Date:1/4/2017)... Jan. 4, 2017  For the thousands of attendees at this year,s ... in connected health and biometric measurement devices and services, will be featuring ... On display in A&D Medical,s special CES Exhibit Suite , the ... expansion of the company,s WellnessConnected product platform.  ... ...
(Date:12/20/2016)... -- The rising popularity of mobility services such ... significant interest in keyless access systems. Following the ... (BLE), biometrics and near-field communication (NFC) are poised ... technologies in the automotive industry. This evolution from ... opens the market to specialist companies such as ...
(Date:12/16/2016)... 16, 2016 The global wearable medical device market, in ... 2021 from USD 5.31 billion in 2016, at a CAGR of ... ... technological advancements in medical devices, launch of a growing number of ... connectivity among healthcare providers, and increasing focus on physical fitness. ...
Breaking Biology News(10 mins):